ENCePP web header
ENCePP web header
  • Ruthsarian
  • Home
  • Sitemap
  • Q & A
  • Notice Board
    • PhEpi & PhV activities
    • Research Funding
    • Conferences & meetings
    • Recruitment
  • Links
  • Contact Us

Links to Studies

Status Official Title Lead Investigator Last Updated
Planned Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: risk awareness and adherence Dr Olaf Klungel 18/02/2020
Planned Impact of EU label changes and pregnancy prevention programme for medicinal products containing valproate and related substances: risk awareness and adherence Dr Olaf Klungel 18/02/2020

  • News
  • About Us
  • ENCePP Documents
  • Training in PhEpi and PV

  • Code of Conduct
  • Standards & Guidances
  • ENCePP Study Seal
  • Public Consultation
  • Glossary of terms

  • Resources Database

  • Partners forum

  • EU PAS Register

  • About EU PAS Register
© 1995-2020 European Medicines Agency | Contact Us | Privacy Policy | Admin Login | Disclaimer

As of 1.2.2020, the UK is no longer an EU Member State. However, EU law still applies to the UK during the transition period.


combined emea eu logo European Medicines Agency Europa Website
Version: 4.4.1.1